Clinical Trials in Phoenix

Showing 4901-4920 of 16,646 trials

A Study of Mavacamten in Participants With HFpEF and Elevation of NT-proBNP With or Without Elevation of cTnT

NCT04766892

This is a Phase 2a proof-of-concept study to assess safety, tolerability, and preliminary efficacy of mavacamten treatment on biomarker levels in participants with heart failure with preserved ejection fraction (HFpEF) and elevation of NT-proBNP with or without elevation of cTnT. Data from this study will inform future study designs of mavacamten in patients with HFpEF.

Heart Failure With Preserved Ejection Fraction

Bristol-Myers Squibb30 participantsStarted Mar 2021

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Tucson, Arizona, United States +18 more locations

COMPLETEDPhase 2< 1 mile

Evaluation of Maralixibat in Biliary Atresia Response Post-Kasai

NCT04524390

A study to evaluate the efficacy and safety of maralixibat in infants with Biliary Atresia (BA) after Hepatoportoenterostomy (HPE, also known as the Kasai procedure).

Biliary Atresia

Mirum Pharmaceuticals, Inc.75 participantsStarted Jul 2021

Phoenix, Arizona, United States • Atlanta, Georgia, United States • New York, New York, United States +19 more locations

A Study of Mavacamten in Participants With HFpEF and Elevation of NT-proBNP With or Without Elevation of cTnT

Evaluation of Maralixibat in Biliary Atresia Response Post-Kasai

Find Trials by Condition in Phoenix

Identifying Predictors of Poor Health-Related Quality-of-Life Among Pediatric Hematopoietic Stem Cell Donors

BIOTRONIK Conduction System Pacing With the Solia Lead

A 3-month Study to Assess the Safety of ONS-5010 in Subjects With Visual Impairment Due to Retinal Disorders

A Clinical Effectiveness Study Examining the Efficacy and Safety of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD)

Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccine MRT5410 in Adult Participants 18 Years of Age and Older

EVAS2 IDE Prospective, Multicenter, Single Arm Safety and Effectiveness Confirmatory Study

Optical Coherence Tomography (OCT) Reference Data Collection Study (S-2015-3)

Safety, PK, PD, Clinical Activity of KT-333 in Adult Patients With Refractory Lymphoma, Large Granular Lymphocytic Leukemia, Solid Tumors

Study of Magrolimab Combinations in Participants With Myeloid Malignancies

7-Day Trial of Sucraid for Alleviating CSID Symptoms in Subjects With Low, Moderate, and Normal Sucrase Levels

Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT411

Study of ORIC-533 in Relapsed or Refractory Multiple Myeloma

Aging Back Clinics

Study to Compare 2 Botulinum Type A Toxins in the Treatment of Glabellar Frown Lines

4D-125 in Patients With X-Linked Retinitis Pigmentosa (XLRP)

A Study of JR-171 in Patients With Mucopolysaccharidosis I

Aldosterone bloCkade for Health Improvement EValuation in End-stage Renal Disease